IP Library Granted Patent US 11,566,278
Granted Patent B2
US 11,566,278 · App. 17/870,697 · Granted Jan 31, 2023

Methods of identifying multiple epitopes in cells

Inventor: Garry P. Nolan (Redwood City, CA)
Assignee: ROCHE SEQUENCING SOLUTIONS, INC.
C12Q1/6806C12Q1/686C12Q1/6816
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,566,278
App. No.
17/870,697
Granted
Jan 31, 2023
Kind
B2
Abstract

The invention provides methods, compositions, kits and devices for the detection of target molecules. In some embodiments, the invention allows for multiplexed target molecule detection.

Claims (29)

1. A method for identifying targets associated with a single cell or cell compartment comprising:

(a) providing a plurality of cells or cell compartments, wherein the cells or cell compartments comprise nucleic acids and are free of rolling circle amplification products,

(b) assembling a cell origination barcode in and/or on individual cells or cell compartments by a method that comprises adding one or more assayable polymer subunit oligonucleotides to the nucleic acids in an ordered manner using a split-pool process; and

(c) sequencing the cell origination barcodes and the nucleic acids, or an amplification product thereof, to produce sequence reads.

2. The method of claim 1 , further comprising analyzing the sequence reads to determine which nucleic acids are associated with which cells or cell compartments.

3. The method of claim 1 , wherein the assembling of (b) is done by ligation, gap-fill/ligation, by extension by a polymerase, hybridization or affinity binding.

4. The method of claim 3 , wherein the ligation is splinted using a bridging oligonucleotide.

5. The method of claim 1 , wherein the cells or cell compartments are mammalian cells or compartments isolated therefrom.

6. The method of claim 1 , wherein the method is performed using a cell suspension.

7. The method of claim 1 , wherein the method is performed using cultured cells, blood cells, cells from a tissue, or a cell compartment isolated therefrom.

8. The method of claim 1 , wherein the method is performed using cells that have been exposed to an agent or genetically modified, or a cell compartment isolated therefrom.

9. The method of claim 1 , wherein the nucleic acids comprise cellular nucleic acids.

10. The method of claim 1 , wherein the nucleic acids comprise genomic DNA or RNA.

11. The method of claim 1 , wherein the nucleic acids comprise cDNA.

12. The method of claim 1 , wherein the nucleic acids comprise methylated nucleic acids.

13. The method of claim 12 , further comprising determining the methylation state of the nucleic acids.

14. The method of claim 1 , wherein the nucleic acids are oligonucleotides.

15. The method of claim 14 , wherein the oligonucleotides are oligonucleotide probes that are directly or indirectly hybridized to nucleic acids in the cells or a compartment thereof.

16. The method of claim 14 , wherein the oligonucleotides are bound to proteins.

17. The method of claim 16 , wherein the oligonucleotides are conjugated to antibodies that are bound to antigens that are in and/or on the cells or cell compartments thereof.

18. The method of claim 1 , wherein the split-pool process comprises multiple rounds of: (i) splitting the cells or cell compartments and adding the assayable polymer subunit oligonucleotides to the nucleic acids while the cells or cell compartments are split; and then (ii) pooling the cells or cell compartments.

19. The method of claim 1 , wherein the nucleic acids are in the cells or cell compartments.

20. The method of claim 19 , wherein the cells or cell compartments are fixed and/or permeabilized.

21. The method of claim 1 , wherein one or more of the assayable polymer subunit oligonucleotides comprises a random sequence.

22. The method of claim 1 , further comprising directly or indirectly adding a biotin to the nucleic acids.

23. The method of claim 22 , wherein the method further comprises enriching for nucleic acids that are biotinylated.

24. The method of claim 1 , wherein the method is performed using cell compartments.

25. The method of claim 1 , wherein the cell or cell compartments of step (a) correspond to a single biomolecular sample.

26. The method of claim 1 , wherein the cell or cell compartments of step (a) correspond to multiple individual biomolecular samples.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2022
From: NOLAN, GARRY P.
To: APPRISE BIO, INC.
Reel/Frame 060595/0176 →
MERGER AND CHANGE OF NAME Recorded Jul 22, 2022
From: APPRISE BIO, INC.; ROCHE SEQUENCING SOLUTIONS, INC.
To: ROCHE SEQUENCING SOLUTIONS, INC.
Reel/Frame 060595/0221 →
Continuity (6)
Continuation 16795203 · Feb 19, 2020
Continuation 16147250 · Sep 28, 2018
Continuation 13981711
Provisional Application 61444067 · Feb 17, 2011
Provisional Application 61437854 · Jan 31, 2011
Related Publication 20220364151A1 · Nov 17, 2022
Cited By (16)
US 12,195,786 US 12,227,793 US 12,234,501 US 12,247,247 US 12,247,248 US 12,252,730 US 12,252,731 US 12,252,733 US 12,252,734 US 12,252,735 US 12,252,736 US 12,252,737 US 12,305,219 US 12,305,220 US 12,305,221 US 12,716,085